MRPL57P6

Across TCGA pan-cancer cohorts, MRPL57P6 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MRPL57P6 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MRPL57P6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MRPL57P6 expression acts as an unfavorable survival marker.

BLCA, ESCA, and UCEC are the cancer types where MRPL57P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
UCEC	DFS	Tertile	II,III,IV	0.621	0.830	.016	24	view →
BRCA	OS	Tertile	III,IV	0.514	0.906	.035	18	view →
LIHC	DFS	Tertile	All	0.034	0.554	<.001	18	view →
SKCM	OS	Tertile	All	0.638	0.872	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MRPL57P6–BLCA (DFS)

Open the BLCA breakdown →